Clinical Trial

GPC3-Targeted PET/CT in Hepatocellular Carcinoma

Name: GPC3-Targeted PET/CT in Hepatocellular Carcinoma — clinical trial record (NCT07677774)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of the study is to evaluate the diagnostic value of GPC3-targeted PET/CT in patients with suspected or histologically/clinically confirmed hepatocellular carcinoma, and to compare with 18F-FDG PET/CT.

Trial Details

NCT Number	NCT07677774
Lead Sponsor	The First Affiliated Hospital of Xiamen University
Conditions	Hepatocellular Carcinoma (HCC), Glypican-3, GPC3-targeted PET/CT
Enrollment	40 participants
Start Date	2026-05-01
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-01